Evaluation of transforming growth factor and vascular endothelial growth factor polymorphisms in Taiwan Chinese patients with pterygium

European Journal of Ophthalmology

Volumn 18, Issue 1, 2008, Pages 21-26

  Bau, D T ^a,b   Chiang, C C ^a,c   Tsai, Yi Yu ^a   Lee, C C ^a   Tsai, Y ^b   Lin, C C ^a   Tsai, C H ^d   Tsai, Fuu Jen ^a,b,d  

^a CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b CHINA MEDICAL UNIVERSITY   (Taiwan)

^c CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^d ASIA UNIVERSITY   (Taiwan)

Author keywords

Polymorphism; Pterygium; Transforming growth factor; Vascular endothelial growth factor

Indexed keywords

TRANSFORMING GROWTH FACTOR BETA1; VASCULOTROPIN;

ADULT; AGED; ARTICLE; CHINESE; EVALUATION; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PTERYGIUM; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; TAIWAN; VOLUNTEER;

EID: 41149150910     PISSN: 11206721     EISSN: None     Source Type: Journal    
DOI: 10.1177/112067210801800104     Document Type: Article

References (35)

1. Hill JC, Maske R. Pathogenesis of pterygium. Eye 1989; 3(Pt 2): 218-26.
2. Kria L, Ohira A, Amemiya T. Immunohistochemical localization of basic fibroblast growth factor, platelet derived growth factor, transforming growth factor-beta and tumor necrosis factor-alpha in the pterygium. Acta Histochem 1996; 98: 195-201.
3. Kria L, Ohira A, Amemiya T. Growth factors in cultured pterygium fibroblasts: immunohistochemical and ELISA analysis. Graefes Arch Clin Exp Ophthalmol 1998; 236: 702-8.
4. Cornand G. Pterygium. Clinical course and treatment. Rev Int Trach Pathol Ocul Trop Subtrop Sante Publique 1989; 66: 31-108.
5. Lee DH, Cho HJ, Kim JT, Choi JS, Joo CK. Expression of vascular endothelial growth factor and inducible nitric oxide synthase in pterygia. Cornea 2001; 20: 738-42.
6. Pinkerton OD, Hokama Y, Shigemura LA. Immunologic basis for the pathogenesis of pterygium. Am J Ophthalmol 1984; 98: 225-8.
7. Blobe GC, Schiemann WP, Lodish HF. Role of transforming growth factor beta in human disease. N Engl J Med 2000; 342: 1350-8.
8. Suzuma K, Naruse K, Suzuma I, et al. Vascular endothelial growth factor induces expression of connective tissue growth factor via KDR, Flt1, and phosphatidylinositol 3-kinase-akt-dependent pathways in retinal vascular cells. J Biol Chem 2000; 275: 40725-31.
9. Amano S, Rohan R, Kuroki M, Tolentino M, Adamis AP. Requirement for vascular endothelial growth factor in wound- and inflammation-related corneal neovascularization. Invest Ophthalmol Vis Sci 1998; 39: 18-22.
10. van Setten GB. Vascular endothelial growth factor (VEGF) in normal human corneal epithelium: detection and physiological importance. Acta Ophthalmol Scand 1997; 75: 649-52.
11. Jin J, Guan M, Sima J, et al. Decreased pigment epithelium-derived factor and increased vascular endothelial growth factor levels in pterygia. Cornea 2003; 22: 473-7.
12. Excoffier L, Slatkin M. Maximum-likelihood estimation of molecular haplotype frequencies in a diploid population. Mol Biol Evol 1995; 12: 921-7.
13. Hinke V, Seek T, Clanget C, Scheidt-Nave C, Ziegler R, Pfeilschifter J. Association of transforming growth factor-beta1 (TGFbeta1) T29 - > C gene polymorphism with bone mineral density (BMD), changes in BMD, and serum concentrations of TGF-beta1 in a population-based sample of postmenopausal german women. Calcif Tissue Int 2001; 69: 315-20.
14. Dushku N, Reid TW. Immunohistochemical evidence that human pterygia originate from an invasion of vimentin-expressing altered limbal epithelial basal cells. Curr Eye Res 1994; 13: 473-81.
15. Di Girolamo N, Coroneo MT, Wakefield D. Active matrilysin (MMP-7) in human pterygia: potential role in angiogenesis. Invest Ophthalmol Vis Sci 2001; 42: 1963-8.
16. Miller JW. Vascular endothelial growth factor and ocular neovascularization. Am J Pathol 1997; 151: 13-23.
17. Muraoka RS, Dumont N, Ritter CA, et al. Blockade of TGF-beta inhibits mammary tumor cell viability, migration, and metastases. J Clin Invest 2002; 109: 1551-9.
18. Siegel PM, Massague J. Cytostatic and apoptotic actions of TGF-beta in homeostasis and cancer. Nat Rev Cancer 2003; 3: 807-21.
19. Tang B, Vu M, Booker T, et al. TGF-beta switches from tumor suppressor to prometastatic factor in a model of breast cancer progression. J Clin Invest 2003; 112: 1116-24.
20. Grainger DJ, Heathcote K, Chiano M, et al. Genetic control of the circulating concentration of transforming growth factor type beta1. Hum Mol Genet 1999; 8: 93-7.
21. Hsieh YY, Chang CC, Tsai FJ, Peng CT, Yeh LS, Lin CC. Polymorphism for transforming growth factor beta 1-509 (TGF-B1-509): association with endometriosis. Biochem Genet 2005; 43: 203-10.
22. Lee KM, Park SK, Hamajima N, et al. Genetic polymorphisms of TGF-beta1 & TNF-beta and breast cancer risk. Breast Cancer Res Treat 2005; 90: 149-55.
23. Stanczuk GA, Tswana SA, Bergstrom S, Sibanda EN. Polymorphism in codons 10 and 25 of the transforming growth factor-beta 1 (TGF-beta1) gene in patients with invasive squamous cell carcinoma of the uterine cervix. Eur J Immunogenet 2002; 29: 417-21.
24. Ohtsuka T, Yamakage A, Yamazaki S. The polymorphism of transforming growth factor-beta1 gene in Japanese patients with systemic sclerosis. Br J Dermatol 2002; 147:458-63.
25. Sugiura Y, Niimi T, Sato S, et al. Transforming growth factor beta1 gene polymorphism in rheumatoid arthritis. Ann Rheum Dis 2002; 61: 826-8.
26. Beranek M, Kankova K, Benes P, et al. Polymorphism R25P in the gene encoding transforming growth factor-beta (TGF-beta1) is a newly identified risk factor for proliferative diabetic retinopathy. Am J Med Genet 2002; 109: 278-83.
27. Edmunds SC, Kelsell DP, Hungerford JL, Cree IA. Mutational analysis of selected genes in the TGFbeta, Wnt, pRb, and p53 pathways in primary uveal melanoma. Invest Ophthalmol Vis Sci 2002; 43: 2845-51.
28. Araria-Goumidi L, Lambert JC, Mann DM, et al. Association study of three polymorphisms of TGF-beta1 gene with Alzheimer's disease. J Neurol Neurosurg Psychiatry 2002; 73: 62-4.
29. Niimi T, Sato S, Sugiura Y, et al. Transforming growth factor-beta gene polymorphism in sarcoidosis and tuberculosis patients, Int J Tuberc Lung Dis 2002; 6: 510-5.
30. Holla LI, Fassmann A, Benes P, Halabala T, Znojil V. 5 polymorphisms in the transforming growth factor-beta 1 gene (TGF-beta 1) in adult periodontitis. J Clin Periodontol 2002; 29: 336-41.
31. Ferrara N, Gerber HR LeCouter J. The biology of VEGF and its receptors. Nat Med 2003; 9: 669-76.
32. Kim I, Ryan AM, Rohan R, et al. Constitutive expression of VEGF, VEGFR-1, and VEGFR-2 in normal eyes. Invest Ophthalmol Vis Sci 1999; 40: 2115-21.
33. Ray D, Mishra M, Ralph S, Read I, Davies R, Brenchley P. Association of the VEGF gene with proliferative diabetic retinopathy but not proteinuria in diabetes. Diabetes 2004; 53: 861-4.
34. Stevens A, Soden J, Brenchley PE, Ralph S, Ray DW. Haplotype analysis of the polymorphic human vascular endothelial growth factor gene promoter. Cancer Res 2003; 63: 812-6.
35. Tsai YY, Lee H, Tseng SH, et al. Null type of glutathione S-transferase M1 polymorphism is associated with early onset pterygium. Mol Vis 2004; 10: 458-61.